Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $153.91 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $57.57 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $55.36 | 4 | $0 (2018) |
| AngioDynamics, Inc. | $40.98 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $40.98 | 1 | AngioDynamics, Inc. ($40.98) |
| 2018 | $61.71 | 4 | Allergan Inc. ($45.60) |
| 2017 | $51.22 | 4 | Merck Sharp & Dohme Corporation ($39.25) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2019 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $40.98 | General |
| Category: VIT | ||||||
| 12/06/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/26/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/22/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/21/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 330 | 658 | $211,029 | $54,658 |
| 2022 | 5 | 305 | 607 | $183,948 | $48,903 |
| 2021 | 6 | 222 | 499 | $127,661 | $37,355 |
| 2020 | 11 | 420 | 790 | $178,169 | $54,807 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 237 | $86,756 | $21,133 | 24.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 196 | $40,901 | $11,943 | 29.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 79 | $25,508 | $7,072 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $18,152 | $4,473 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 44 | $16,566 | $4,291 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 25 | $13,030 | $3,216 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 39 | $10,116 | $2,531 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 208 | $75,808 | $19,850 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 64 | 231 | $46,200 | $12,700 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $24,198 | $6,324 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 62 | $23,528 | $6,212 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 55 | $14,214 | $3,817 | 26.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 281 | $55,638 | $15,849 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 75 | $22,275 | $6,812 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 47 | 50 | $18,900 | $5,281 | 27.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $13,950 | $4,188 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 50 | $10,250 | $3,318 | 32.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $6,648 | $1,906 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 65 | 213 | $55,742 | $17,856 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 224 | $42,866 | $13,061 | 30.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 86 | 92 | $32,660 | $10,183 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 88 | $22,788 | $6,610 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 56 | $9,538 | $2,767 | 29.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $7,784 | $2,637 | 33.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $4,265 | $1,191 | 27.9% |
About Dr. Ramona Popa, MD
Dr. Ramona Popa, MD is a Infectious Disease healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730278623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramona Popa, MD has received a total of $153.91 in payments from pharmaceutical and medical device companies, with $40.98 received in 2019. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($153.91).
As a Medicare-enrolled provider, Popa has provided services to 1,277 Medicare beneficiaries, totaling 2,554 services with total Medicare billing of $195,723. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Tacoma, WA
- Active Since 10/11/2006
- Last Updated 12/08/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1730278623
Products in Payments
- AVYCAZ (Drug) $46.03
- ISENTRESS (Drug) $37.55
- ZEPATIER (Drug) $17.81
- TEFLARO (Drug) $11.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Tacoma
Lawrence Schwartz, Md, MD
Infectious Disease — Payments: $2,562
Dr. Roumen Iordanov, M.d, M.D
Infectious Disease — Payments: $1,039
Elizabeth Lien, M.d, M.D
Infectious Disease — Payments: $934.00
Dr. Michael Stein, M.d, M.D
Infectious Disease — Payments: $482.02
David Mceniry, M.d, M.D
Infectious Disease — Payments: $164.10
Dr. Susan Fraser, Md, MD
Infectious Disease — Payments: $148.16